A Company Profile and Key Details

Q: Who are the executives of A?

Mr. Michael R. McMullenChief Executive Officer, Pres & DirectorMr. Samraat S. RahaSenior Vice President and Pres of Diagnostics & Genomics GroupMr. John KohlSenior Vice President & Chief Information OfficerMr. Padraig McDonnellSenior Vice President & Pres of Agilent Cross Lab GroupMr. Michael TangSenior Vice President, Gen. Counsel & Sec.Ms. Allison BallmerSenior Vice President of Strategy & Corporation Devel.Mr. Henrik Ancher-JensenSenior Vice President and Pres of Order Fulfillment & Supply ChainMr. Rodney GonsalvesPrincipal Accounting Officer, Vice President & Corporation ControllerMr. Dominique P. GrauSenior Vice President of HR & Global CommunicationsMr. Robert W. McMahonSenior Vice President & Chief Financial OfficerDr. Darlene J. S. Solomon Ph.D.Chief Technology Officer & Senior Vice PresidentMr. Jacob ThaysenSenior Vice President and Pres of Life Sciences & Applied Markets Group

NYSE : A

Agilent Technologies

$129.64

-3.34-2.51%

At Close 4:00 PM

70.39

B+ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Agilent Technologies, Inc. (A) stock declined over -2.51%, trading at $129.64 on NYSE, down from the previous close of $132.98. The stock opened at $132.19, fluctuating between $129.35 and $133.45 in the recent session.

Stock Snapshot

132.98

Prev. Close

36.75B

Market Cap

129.35

Day Low

28.18

P/E Ratio

4.6

EPS (TTM)

5.63

Cash Flow per Share

132.19

Open

283.5M

Number of Shares

133.45

Day High

99.64%

Free Float in %

21.12

Book Value

1.2M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 05, 2026	132.19	133.45	129.35	129.64	1.48M
Feb 04, 2026	132.31	134.87	132.31	132.98	1.96M
Feb 03, 2026	135.39	137.85	131.56	132.14	2.43M
Feb 02, 2026	132.63	135.57	132.12	135.39	1.49M
Jan 30, 2026	131.94	133.94	131.08	133.85	1.81M
Jan 29, 2026	132.75	133.31	129.63	133.27	1.92M
Jan 28, 2026	135.40	135.57	133.40	133.87	1.47M
Jan 27, 2026	134.49	137.09	134.06	135.95	1.35M
Jan 26, 2026	134.72	136.96	134.10	135.65	1.55M
Jan 23, 2026	138.00	138.37	133.96	135.05	1.81M
Jan 22, 2026	139.30	141.19	138.43	138.63	1.45M
Jan 21, 2026	136.22	140.47	136.02	139.77	1.99M
Jan 20, 2026	138.00	138.77	134.63	135.83	3.26M
Jan 16, 2026	144.20	144.88	139.49	139.64	2.58M
Jan 15, 2026	146.59	146.90	144.68	144.83	1.66M
Jan 14, 2026	146.41	148.37	145.51	145.92	1.68M
Jan 13, 2026	148.57	150.10	143.14	146.32	2.59M
Jan 12, 2026	148.60	150.00	146.91	147.99	1.13M
Jan 09, 2026	147.48	150.03	147.15	148.52	1.81M
Jan 08, 2026	146.74	148.74	145.37	145.76	1.66M

Contact Details

Santa Clara, CA 95051

United States

https://www.agilent.com 800 227 9770

About Company

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Stock Peers

MTD

-6.88-0.50%

Mettler-Toledo International Inc.$1,382.85 TMO

-22.86-4.04%

Thermo Fisher Scientific Inc.$542.36 WAT

-7.44-1.94%

Waters Corporation$376.89 DHR

-3.78-1.72%

Danaher Corporation$215.75 DGX

3.07+1.62%

Quest Diagnostics Incorporated$192.30 CRL

-17.92-8.89%

Charles River Laboratories International, Inc.$183.70 IQV

-21.58-10.65%

IQVIA Holdings Inc.$180.96 RVTY

-4.31-4.15%

Revvity, Inc.$99.52 QGEN

-0.48-0.93%

Qiagen N.V.$51.23 ENZ

-0.0678-17.77%

Enzo Biochem, Inc.$0.31

Company Overview

Agilent Technologies, Inc. (NYSE:A) closed at $129.64 USD, losing -$3.34 (-2.51%) from the previous close of $132.98. The stock is currently mid-range between its 52-week high and low $96.43 and $160.27. With a market capitalization of about $36.75 billion, Agilent Technologies, Inc. is classified as a large-cap and shows market-like volatility (beta ~1.30). Key stats such as the average daily volume over the past year has been around 2.01 million shares, volume is running light vs its 52-week average. Headquartered in Santa Clara, CA, Agilent Technologies, Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Padraig McDonnell, the company employs approximately 17,900 people and listed since November 18, 1999. Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 -6.43%, SMA50 -8.35%, SMA200 0.98%). The stock’s 14-day RSI is 33.55 (weak momentum), while the ATR of 3.67 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -19.11% below its high and over 34.44% above its low. Average 10-day trading volume of 1.72 million shares is below the 3-month average of 1.91 million, indicating normal recent market interest.

Valuation Metrics

Agilent Technologies, Inc. trades at a P/E ratio of 28.19, slightly below the S&P 500 average, with a price-to-sales ratio of 5.3 and a price-to-book ratio of 5.45 trading at moderately above to book value. The P/FCF stands at 31.94, also below market averages.

Dividend & Fair Value

Agilent Technologies, Inc. last paid a dividend of 1.0 per share, this equals a trailing yield of roughly 0.63%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $78.00. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Agilent Technologies, Inc. generated EPS of $4.57 over the past year. Five-year average earnings growth is 14.68%. Wall Street analysts project EPS growth of 9.13% annually over the next five years. The latest quarter delivered EPS of $1.59. The next quarter is forecast at $1.37. Next year's EPS is expected at $10.66. Analyst sentiment is bullish. Analyst rating data shows there are 11 Strong Buy ratings, 7 Buy ratings, 11 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $185.00 to $115.00. The high target offers 42.7% upside. The low target suggests -11.29% downside. The mean target is $155.55. This offers 19.99% upside. Agilent Technologies, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 24, 2025, missed forecasts by 0.63%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include 4.76% in August 21, 2024.

Shareholding & Insider Activity

Agilent Technologies, Inc. has 283.50 million shares outstanding. The public float is 282.52 million shares, elevated short interest at 1.60% of float. This equals 3.99 million shares. The short ratio is 1.99 days. Institutional investors hold 91.45% of the float. Insiders own 0.27%. McMullen Michael R. holds 253.91 thousand shares, Doak Mark has 135.68 thousand shares and Thaysen Jacob has 84.46 thousand shares. Over the past six months, insider transactions show net selling. They sold 21.00 thousand shares across 5 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Agilent Technologies generated $6.95B in revenue, or $24.46 per share. Gross margin was 52.43%, operating margin 21.29%, and net profit margin 18.75%. Returns are healthy, with ROA at 10.24% and ROE at 19.33%.
On valuation metrics, Agilent Technologies trades at a P/E of 28.19, P/S of 5.30 and P/B of 5.45. The current ratio is 1.96 and quick ratio is 1.52. Operationally, the company’s inventory turnover is 3.22 and cash conversion cycle is 128.37 days. Debt-to-equity is 0.50, supported by a cash flow-to-debt ratio of 0.46.

Quarterly Financial Highlights

For the quarter ended Oct 31, 2025, Agilent Technologies posted revenue of $6.95B, down slightly from $6.51B in the prior quarter. Gross profit was $3.64B (margin 52.43%). Operating income was $1.48B (margin 21.3%). Net income was$1.30B (EPS $4.59).
The company ended the quarter with $1.79B in cash and short-term investments, a total debt of $3.35B, and net debt of $1.57B. Total assets were $12.73B, with equity of $6.74B. Financials further reflected stability, with operating cash flow of $1.56B, free cash flow of $1.15B, and capital expenditures of - $407.00M.

Price Forecast & Outlook

Our AI price prediction model suggests that Agilent Technologies, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -5.26%, with price expected at $122.82 by February 19, 2026, within a range of $118.53 to $127.69 3-Month Outlook: Projected fall of -27.13%, reaching $94.47 by May 05, 2026, with a range of $89.18 to $99.03. 1-Year Outlook: Projected gain of 6.76%, with price at $138.40 by February 05, 2027, within a range of $133.22 to $142.69.

Key Takeaways

Agilent Technologies, Inc. (NYSE:A) shares are flat -0.18% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Agilent Technologies, Inc. trading at a premium to the broader market with a P/E of 28.19. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $148.83, suggesting 14.8% upside. Our AI forecast model points to short-term weakness (-5.26% over two weeks), a medium-term fall (-27.13% over three months), and a longer-term gain (6.76% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Agilent Technologies, Inc. (A) stock price?

Agilent Technologies, Inc. (NYSE: A) stock price is $129.64 in the last trading session. During the trading session, A stock reached the peak price of $133.45 while $129.35 was the lowest point it dropped to. The percentage change in A stock occurred in the recent session was -2.51% while the dollar amount for the price change in A stock was - $3.34.

A's industry and sector of operation?

The NYSE listed A is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Agilent Technologies, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of A?

Mr. Michael R. McMullen
Chief Executive Officer, Pres & Director
Mr. Samraat S. Raha
Senior Vice President and Pres of Diagnostics & Genomics Group
Mr. John Kohl
Senior Vice President & Chief Information Officer
Mr. Padraig McDonnell
Senior Vice President & Pres of Agilent Cross Lab Group
Mr. Michael Tang
Senior Vice President, Gen. Counsel & Sec.
Ms. Allison Ballmer
Senior Vice President of Strategy & Corporation Devel.
Mr. Henrik Ancher-Jensen
Senior Vice President and Pres of Order Fulfillment & Supply Chain
Mr. Rodney Gonsalves
Principal Accounting Officer, Vice President & Corporation Controller
Mr. Dominique P. Grau
Senior Vice President of HR & Global Communications
Mr. Robert W. McMahon
Senior Vice President & Chief Financial Officer
Dr. Darlene J. S. Solomon Ph.D.
Chief Technology Officer & Senior Vice President
Mr. Jacob Thaysen
Senior Vice President and Pres of Life Sciences & Applied Markets Group

How A did perform over past 52-week?

A's closing price is 34.44% higher than its 52-week low of $96.43 where as its distance from 52-week high of $160.27 is -19.11%.

How many employees does A have?

Number of A employees currently stands at 17,900.

Link for A official website?

Official Website of A is: https://www.agilent.com

How do I contact A?

A could be contacted at phone 800 227 9770 and can also be accessed through its website. A operates from 5301 Stevens Creek Boulevard, Santa Clara, CA 95051, United States.

How many shares of A are traded daily?

A stock volume for the day was 1.2M shares. The average number of A shares traded daily for last 3 months was 2.01M.

What is the market cap of A currently?

The market value of A currently stands at $36.75B with its latest stock price at $129.64 and 283.5M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	17900
Beta	1.29
Sales or Revenue	$6.95B
5Y Sales Change%	0.421%
Fiscal Year Ends	October
Sector	Healthcare
Industry	Medical - Diagnostics & Research

A Company Profile and Key Details

Agilent Technologies

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Valuation Metrics

Key Takeaways

Price Forecast & Outlook